Melanie Schaffler

Melanie Schaffler, PhD, is a Regulatory Writer at Novo Nordisk since August 2024 and has been an Editorial Board Member and Writer for the Pain Research Forum at the International Association for the Study of Pain since January 2021. Previous experience includes serving as a Regulatory Affairs Associate at Teva Pharmaceuticals and a Medical Writing Intern at OrtleyBio. Melanie received a Neuroscience PhD from the University of Pennsylvania, where research achievements include multiple publications and presentations at international conferences. Additional roles include a Junior Specialist at UC Davis Health and research assistant positions at Wesleyan University. Melanie's expertise encompasses neuroscience, regulatory writing, and pain research communication.